Primary fallopian tube carcinoma - case report

Primary fallopian tube carcinoma is a rare gynecological malignancy and it accounts for about 1% of all gynecological malignancies. Etiological factors are not sufficiently known, but most commonly specified are infertility, nulliparity, and pelvic inflammatory disorder. It is most often asymptomatic, although, a triad reported by Latzko including a vaginal watery discharge, colic like pelvic pain, presence of tumor mass in pelvis, is mentioned as pathognomonic. In the present case, it was primary fallopian tube carcinoma, in FIGO Stage IA. After complete abdominal hysterectomy with lymph node dissection, in line with the expert council’s decision, no adjuvant chemotherapy was administered. PET CT in June 2017, two years after the surgical treatment, presented both some metastatic changes in lungs and enlarged retroperitoneal lymph nodes and after this finding, and chemotherapy with carboplatin was begun. The therapy implies surgical treatment being hysterectomy with adnexectomy, but also retroperitoneal lymph node dissection as well, considering that it more often affects lymphatic glands than epithelial ovarian cancer (EOC). It can be misinterpreted with EOC in a pathological sense. In addition to a surgical treatment, the most common form of chemotherapy is platinum-combined with taxanes.

Fallopian tube carcinoma; Epithelial ovarian cancer, Pelvic inflammatory disorder; Chemotherapy; Platinum; Taxanes

[1] Kalampokas E., Kalampokas T., Tourountous I.: “Primary fallopian tube carcinoma”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2013, 169, 155.

[2] Wang P.H., Liu R.S., Li Y.F., Ng H.T., Yuan C.C.: “Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report”. Gynecol. Oncol., 2000, 77, 44.

[3] King A., Seraj I.M., Thrasher T., Slater J., Wagner R.J.: “Fallopian tube carcinoma: aclinicopathological study of 17 cases”. Gynecol. Oncol., 1989, 33, 351.

[4] Riska A., Lemien A.: “Updating on primary fallopian tube carcinoma”. Acta Obstet. Gynecol. Scand., 2007, 85, 1419.

[5] Jurgen M.J.P., Paul J.V.D., Ronald P.Z., Jan W.J., Ria J.J.P.K, Fred H.M., et al.: “Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer”. J. Pathol., 2001, 195, 451.

[6] Lawson F., Lees C., Kelleher C.: “Primary cancer of fallopian tube”. In: Studd J. (ed). Progress in Obstetrics and Gynecology. London, UK: Churchill Livingstone, 1996, 393.

[7] Kietpeerakool C., Suprasert P., Srisomboon J., Pantusart A.: “Primary carcinoma of fallopian tube: A clinicopathologic analysis of 27 patients”. J. Med. Assoc. Thai., 2005, 88, 1338.

[8] Pectasides D., Pectasides E., Econompoulus T.: “Fallopian tube carcinoma: a review”. Oncologist, 2006, 11, 902.

[9] Rose P., Piver M.S, Tsuleada Y.: “Fallopian tube cancer – The Rosewell Park experience”. Cancer, 1990, 66, 2661.

[10] Gunter J.: “Chronic pelvic pain: An integrated approach to diagnosis and treatment”. Obstet. Gynecol. Surv., 2003, 58, 615.